required, that might reduce the risk of transmission to others, as is being attempted in South Africa. 2 As case detection and treatment for MDR tuberculosis is scaled up internationally, 3 how to care for patients who have exhausted all treatment options with existing second-line drugs will become increasingly important. Currently, no third-line treatment for tuberculosis exists. Until newer drugs become available, we will need to care for such patients in a manner that balances the risk of ongoing transmission with individual human rights. The health system must still support patients in whom treatment has failed. The provision of homebased palliative care, for example, is likely to be more humane and less costly to health services compared with involuntary detention. 4 Although a small proportion of patients might realistically be classifi ed as recalcitrant, and legal means may be necessary to restrict transmission, we feel that every eff ort should be made to support patients, either to continue treatment if they so wish, or to live out the remainder of their lives in a manner that minimises the risk of transmission to others. 5 In this case, the threat of incarceration is also likely to further reduce the chances that this patient will be located. We feel that such patients should not be managed by an automatic resort to legal coercion.
We declare that we have no confl icts of interest. 
*Helen

MDR tuberculosis and non-compliance with therapy
Suheir Ereqat and colleagues 1 described a patient with multidrugresistant (MDR) tuberculosis who has defaulted after 2 years of treatment and is untraceable. They lament the absence of legal means by which this patient might be forced to return to Palestine and continue treatment. We believe this approach puts a mistaken emphasis on legal coercion that is neither eff ective nor humane. If this patient failed treatment, as it would seem, an understanding of the reasons for treatment failure would be important. Did the patient have a history of defaulting treatment previously and, if so, what counselling did this patient receive? Aside from directly observed treatment, what support was off ered to empower him to continue his treatment? What further treatment do the authors suggest should be prescribed? Forcing a patient to continue an ineff ective, toxic regimen that results in no clear benefi t is clearly diffi cult. For patients like these, attention could be more usefully directed at exploring possible regimens with better chances of cure; and securing an appropriate environment, such as supportive accommodation with access to counselling and palliative care when
Authors' Reply
We thank Helen Cox and colleagues for their comments, but point out that we do not disagree with them. Health is a human right that should be guaranteed through legal and social policies. We endeavoured in our letter 1 to ask questions, not to propose an answer. Naturally the Palestinian Health Authority made all eff orts to keep the patient in therapy. Our letter was directed at a recalcitrant patient, one who has had all counselling suggested and who then disappeared and thus refused further therapy. What are our obligations as doctors in this case and what do we do if the patient goes to a diff erent country? As multidrugresistant microbes are becoming an increasing health and community problem, should thought be given to making some such infections notifi able diseases, as is done in Australia for various other diseases?
2 Such a move could solve many problems and allow some control of patients.
Cox and colleagues state that no new third-line treatment for tuberculosis exists, but happily the situation is not quite that bleak. 3, 4 We would pose the question: if this individual were a teacher of young children, would he be allowed to work? And if he moved and left treatment, what are the legal obligations and constraints on his physicians or the relevant health authority to notify people at his destination or issue a general warning? We too believe that any form of control should not aff ect the patient's dignity, but the question of compulsory isolation for
